CCM Investment Advisers’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.5M | Buy |
73,525
+2,512
| +4% | +$540K | 1.43% | 27 |
|
|
2026
Q1 | $15.4M | Sell |
71,013
-1,698
| -2% | -$377K | 1.48% | 29 |
|
|
2025
Q4 | $16.6M | Sell |
72,711
-1,127
| -2% | -$257K | 1.59% | 27 |
|
|
2025
Q3 | $17.1M | Sell |
73,838
-7,585
| -9% | -$1.54M | 1.68% | 22 |
|
|
2025
Q2 | $15.1M | Buy |
81,423
+3,902
| +5% | +$725K | 1.63% | 25 |
|
|
2025
Q1 | $16.2M | Sell |
77,521
-4,723
| -6% | -$918K | 1.99% | 20 |
|
|
2024
Q4 | $14.6M | Buy |
82,244
+1,371
| +2% | +$252K | 1.62% | 26 |
|
|
2024
Q3 | $16M | Sell |
80,873
-6,991
| -8% | -$1.3M | 1.78% | 23 |
|
|
2024
Q2 | $15.1M | Sell |
87,864
-527
| -0.6% | -$87.3K | 1.77% | 22 |
|
|
2024
Q1 | $16.1M | Sell |
88,391
-5,530
| -6% | -$953K | 1.93% | 19 |
|
|
2023
Q4 | $14.6M | Sell |
93,921
-60
| -0.1% | -$8.75K | 1.79% | 24 |
|
|
2023
Q3 | $14M | Buy |
93,981
+572
| +0.6% | +$84K | 1.93% | 17 |
|
|
2023
Q2 | $12.6M | Buy |
93,409
+3,289
| +4% | +$482K | 1.69% | 26 |
|
|
2023
Q1 | $14.4M | Buy |
90,120
+4,648
| +5% | +$711K | 2.03% | 16 |
|
|
2022
Q4 | $13.8M | Sell |
85,472
-4,341
| -5% | -$666K | 2.19% | 13 |
|
|
2022
Q3 | $12.1M | Sell |
89,813
-2,474
| -3% | -$355K | 2.05% | 19 |
|
|
2022
Q2 | $14.1M | Sell |
92,287
-1,968
| -2% | -$301K | 2.27% | 7 |
|
|
2022
Q1 | $15.3M | Sell |
94,255
-7,536
| -7% | -$1.09M | 2.08% | 11 |
|
|
2021
Q4 | $13.8M | Buy |
101,791
+1,729
| +2% | +$204K | 1.67% | 29 |
|
|
2021
Q3 | $10.8M | Buy |
100,062
+2,398
| +2% | +$274K | 1.4% | 46 |
|
|
2021
Q2 | $11M | Buy |
97,664
+10,286
| +12% | +$1.16M | 1.41% | 46 |
|
|
2021
Q1 | $9.46M | Buy |
87,378
+1,535
| +2% | +$164K | 1.28% | 47 |
|
|
2020
Q4 | $9.2M | Buy |
85,843
+10,814
| +14% | +$1.04M | 1.33% | 47 |
|
|
2020
Q3 | $6.57M | Buy |
+75,029
| New | +$7.06M | 1.07% | 49 |
|
|
2020
Q1 | – | Sell |
-2,657
| Closed | -$235K | – | 64 |
|
|
2019
Q4 | $235K | Sell |
2,657
-175
| -6% | -$14.5K | 0.04% | 67 |
|
|
2019
Q3 | $214K | Sell |
2,832
-940
| -25% | -$64.4K | 0.04% | 65 |
|
|
2019
Q2 | $274K | Sell |
3,772
-6,495
| -63% | -$511K | 0.05% | 64 |
|
|
2019
Q1 | $827K | Sell |
10,267
-10,887
| -51% | -$891K | 0.14% | 56 |
|
|
2018
Q4 | $1.95M | Sell |
21,154
-10,645
| -33% | -$936K | 0.39% | 56 |
|
|
2018
Q3 | $3.01M | Sell |
31,799
-45,288
| -59% | -$4.29M | 0.55% | 54 |
|
|
2018
Q2 | $7.14M | Sell |
77,087
-46,865
| -38% | -$4.58M | 1.36% | 40 |
|
|
2018
Q1 | $11.7M | Sell |
123,952
-3,568
| -3% | -$392K | 2.29% | 9 |
|
|
2017
Q4 | $12.3M | Sell |
127,520
-6,726
| -5% | -$634K | 2.38% | 6 |
|
|
2017
Q3 | $11.9M | Sell |
134,246
-7,455
| -5% | -$567K | 2.3% | 7 |
|
|
2017
Q2 | $10.3M | Sell |
141,701
-5,515
| -4% | -$371K | 2.01% | 13 |
|
|
2017
Q1 | $9.59M | Sell |
147,216
-180
| -0.1% | -$11.3K | 1.91% | 15 |
|
|
2016
Q4 | $9.23M | Sell |
147,396
-1,575
| -1% | -$96.1K | 1.95% | 19 |
|
|
2016
Q3 | $9.39M | Sell |
148,971
-201,294
| -57% | -$13M | 1.98% | 19 |
|
|
2016
Q2 | $21.7M | Sell |
350,265
-13,762
| -4% | -$839K | 2.02% | 12 |
|
|
2016
Q1 | $20.8M | Sell |
364,027
-8,701
| -2% | -$485K | 1.95% | 16 |
|
|
2015
Q4 | $22.1M | Buy |
372,728
+45,741
| +14% | +$2.63M | 2.07% | 24 |
|
|
2015
Q3 | $17.8M | Sell |
326,987
-2,831
| -0.9% | -$184K | 1.77% | 30 |
|
|
2015
Q2 | $22.2M | Buy |
329,818
+22,175
| +7% | +$1.45M | 2.04% | 9 |
|
|
2015
Q1 | $18M | Sell |
307,643
-34,577
| -10% | -$2.09M | 1.76% | 29 |
|
|
2014
Q4 | $22.4M | Sell |
342,220
-32,339
| -9% | -$2.04M | 2.04% | 16 |
|
|
2014
Q3 | $21.6M | Buy |
374,559
+25,998
| +7% | +$1.44M | 1.93% | 22 |
|
|
2014
Q2 | $19.7M | Sell |
348,561
-35,766
| -9% | -$1.88M | 1.8% | 29 |
|
|
2014
Q1 | $19.8M | Sell |
384,327
-13,295
| -3% | -$672K | 1.96% | 23 |
|
|
2013
Q4 | $21M | Buy |
397,622
+18,519
| +5% | +$910K | 1.96% | 18 |
|
|
2013
Q3 | $17M | Buy |
379,103
+74,304
| +24% | +$3.29M | 1.68% | 22 |
|
|
2013
Q2 | $12.6M | Buy |
+304,799
| New | +$13.3M | 1.3% | 37 |
|
Other funds holding ABBV
CCM Investment Advisers's ABBV Position: Q2 2026 in Review
CCM Investment Advisers increased its AbbVie (ABBV) stake by 3.5% in Q2 2026, buying an estimated $540K and bringing the position to 73,525 shares worth $18.5M. The position accounts for 1.43% of the portfolio, ranked #27.
CCM Investment Advisers first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $22.4M in Q4 2014. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- CCM Investment Advisers held 73,525 shares of AbbVie worth $18.5M as of Q2 2026.
- CCM Investment Advisers bought 2,512 AbbVie shares in Q2 2026, an estimated $540K.
- AbbVie made up 1.43% of CCM Investment Advisers's portfolio in Q2 2026, its #27 holding.
- CCM Investment Advisers first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- CCM Investment Advisers's AbbVie position peaked at $22.4M in Q4 2014.
- 4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on CCM Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.